The American Journal of Managed Care5h
Suzetrigine: First-in-Class Non-Opiate Pain Therapy is Approved by FDA
Suzetrigine (Journavx) is the first new drug approved to treat acute pain in over 20 years and the first to be classified as ...
CNET on MSN5d
Microcurrent Devices: Effectiveness, Tips for Use and Are They Worth the Money? We Asked Skin Experts
If you have a microcurrent device on your wishlist, here are some benefits and drawbacks to consider before you buy one.
7 Skin Care Tools Worth The Splurge, According To Top Facialists
The ZIIP Halo, Therabody TheraFace Depuffing Wand, and more of the best skin care tools of 2025, according to top ...
The New York Times19d
Chronic Pain Is a Hidden Epidemic. It’s Time for a Revolution.
Allan Basbaum, who oversees a pain research lab at the University of California, San Francisco, made an analogy to recent breakthroughs in cancer research. For decades, cancer treatment focused on ...